Pneumococcal conjugate second or third-dose vaccines (PCVc) in Togo
Togo: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 89.0% in 2025. ◆ Volatile
Latest (2025)
89.0%
Change on year
unchanged
World rank
72nd
of 194 countries
All-time high
90.0%
in 2021
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Togo, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Togo is 89.0%, measured in 2025.
Compared with earlier readings it is up 15.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Togo peaked at 90.0% in 2021 and was at its lowest, 0.0%, in 2008.
Togo ranks 72nd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Togo, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 25.0% | — |
| 2015 | 77.0% | +208.0% |
| 2016 | 82.0% | +6.5% |
| 2017 | 84.0% | +2.4% |
| 2018 | 84.0% | +0.0% |
| 2019 | 87.0% | +3.6% |
| 2020 | 87.0% | +0.0% |
| 2021 | 90.0% | +3.4% |
| 2022 | 90.0% | +0.0% |
| 2023 | 89.0% | -1.1% |
| 2024 | 89.0% | +0.0% |
| 2025 | 89.0% | +0.0% |
Togo compared with similar countries
- Togo's 89.0% is above the median for lower middle income countries, which is 84.0%, 1.1× the median. (47 countries reporting)
- Togo's 89.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 43.9% | 0.0% | 87.0% | 10 |
| 2020s | 89.0% | 87.0% | 90.0% | 6 |
Countries ranked near Togo
More health data for Togo
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7948 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 875 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,021 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 4 (2025)
- Population ages 00-04, female, annual growth rate 2.86 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0681 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Togo?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Togo was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Togo?
- The highest recorded value was 90.0% in 2021.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Togo?
- The lowest recorded value was 0.0% in 2008.
- How does Togo rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Togo ranks 72nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Togo?
- Over the last ten years it is up 15.6%. The long-run trend across the full record is volatile.
- Where does this Togo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).